assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_001547975.1_ASM154797v1	NZ_AP014657	Mycoplasma arginini strain HAZ145_1 isolate Mycoplasma arginini #HAZ145_1	1	120898-122921	1,1,1,2	PILER-CR,CRISPRCasFinder,CRT,PILER-CR	no	cas9,cas1,cas2	cas9,cas1,cas2,DEDDh	Type II-A, or Type II-C?,Type II-B,Type II-C, Type II-B	AAAGATATTTTTGTGCTGTACAATTTCTTATTAGAGTAAAAC,ATTTTTGTGCTGTACAATTTCTTATTAGAGTAAAAC,NNNNNNNNNNATTTTTGTGCTGTACAATTTCTTATTAGAGTAAAAC,ATTTTTGTGCTGTACAATTTCTTATTAGAGTAAAAC	42,36,46,36	0	0	NA	NA	NA:NA:NA:NA	19,30,30,19	30	TypeII-A,orTypeII-C?,TypeII-B,TypeII-C,TypeII-B	cas9,cas1,cas2,DEDDh	NA|356aa|up_7|NZ_AP014657.1_110247_111315_-,NA|169aa|down_4|NZ_AP014657.1_126518_127025_-	NA|221aa|up_9|NZ_AP014657.1_108284_108947_-	PRK11713, PRK11713, 16S ribosomal RNA methyltransferase RsmE; Provisional	NA|376aa|up_8|NZ_AP014657.1_109057_110185_-	cd02201, FtsZ_type1, Filamenting temperature sensitive mutant Z, type 1	NA|356aa|up_7|NZ_AP014657.1_110247_111315_-	NA	NA|304aa|up_6|NZ_AP014657.1_111318_112230_-	PRK00050, PRK00050, 16S rRNA (cytosine(1402)-N(4))-methyltransferase RsmH	NA|147aa|up_5|NZ_AP014657.1_112226_112667_-	PRK00326, PRK00326, transcriptional regulator MraZ	NA|170aa|up_4|NZ_AP014657.1_113675_114185_+	pfam13518, HTH_28, Helix-turn-helix domain	NA|286aa|up_3|NZ_AP014657.1_114226_115084_+	PHA02517, PHA02517, putative transposase OrfB; Reviewed	cas9|1176aa|up_2|NZ_AP014657.1_115199_118727_-	cd09643, Csn1, CRISPR/Cas system-associated protein Cas9	cas1|290aa|up_1|NZ_AP014657.1_118930_119800_+	TIGR03639, cas1_NMENI, CRISPR-associated endonuclease Cas1, subtype II/NMENI	cas2|98aa|up_0|NZ_AP014657.1_119831_120125_+	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	NA|283aa|down_0|NZ_AP014657.1_123134_123983_+	PRK02193, truB, tRNA pseudouridine synthase B; Provisional	NA|269aa|down_1|NZ_AP014657.1_124001_124808_+	pfam08282, Hydrolase_3, haloacid dehalogenase-like hydrolase	NA|285aa|down_2|NZ_AP014657.1_124855_125710_+	PRK07143, PRK07143, hypothetical protein; Provisional	NA|243aa|down_3|NZ_AP014657.1_125741_126470_-	cd00311, TIM, Triosephosphate isomerase (TIM) is a glycolytic enzyme that catalyzes the interconversion of dihydroxyacetone phosphate and D-glyceraldehyde-3-phosphate	NA|169aa|down_4|NZ_AP014657.1_126518_127025_-	NA	NA|836aa|down_5|NZ_AP014657.1_127123_129631_-	COG4608, AppF, ABC-type oligopeptide transport system, ATPase component [Amino acid transport and metabolism]	NA|353aa|down_6|NZ_AP014657.1_129620_130679_-	COG0444, DppD, ABC-type dipeptide/oligopeptide/nickel transport system, ATPase component [Amino acid transport and metabolism / Inorganic ion transport and metabolism]	NA|437aa|down_7|NZ_AP014657.1_130798_132109_-	COG1173, DppC, ABC-type dipeptide/oligopeptide/nickel transport systems, permease components [Amino acid transport and metabolism / Inorganic ion transport and metabolism]	NA|376aa|down_8|NZ_AP014657.1_132132_133260_-	COG0601, DppB, ABC-type dipeptide/oligopeptide/nickel transport systems, permease components [Amino acid transport and metabolism / Inorganic ion transport and metabolism]	NA|928aa|down_9|NZ_AP014657.1_133266_136050_-	cd08504, PBP2_OppA, The substrate-binding component of an ABC-type oligopetide import system contains the type 2 periplasmic binding fold
